• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium & Barium), Technique (X-Ray, CT, MRI, Cath Lab & Ultrasound) & Application (Radiology, Interventional Radiology & Interventional Cardiology) – Global Trends & Forecast To 2017 - Product Image

Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium & Barium), Technique (X-Ray, CT, MRI, Cath Lab & Ultrasound) & Application (Radiology, Interventional Radiology & Interventional Cardiology) – Global Trends & Forecast To 2017

  • Published: January 2013
  • Region: Global
  • 286 Pages
  • Markets and Markets

FEATURED COMPANIES

  • Cmc Contrast Ab
  • Covidien
  • Daiichi Sankyo Co., Ltd.
  • Ge Healthcare
  • Genovis Ab
  • Guerbet Group
  • MORE

Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium & Barium), By Technique (X-ray, CT, MRI, Cath Lab & Ultrasound) & By Application (Radiology, Interventional Radiology & Interventional Cardiology) - Global Trends & Forecast to 2017

Contrast agents have evolved significantly over the past century, from barium and iodine-based agents that were used initially by medical practitioners and radiologists, to the more advanced agents like radiopharmaceuticals and gold nanoparticles that are currently in use. Sophisticated techniques such as targeted MRI imaging and gas microbubble technology in ultrasound will prove to be essential drivers in the widespread use of contrast agents in the future.

The global contrast media market is broadly segmented into barium-based, iodinated and gadolinium-based contrast media. These products are further categorized based on the medical procedure (X-ray, CT, MRI, ultrasound, and catheterization laboratory), route of administration (oral, injection, rectal, and urethral), medical indication (cardiovascular, respiratory, musculoskeletal, gastrointestinal, and neurology, nephrology and oncology) and finally READ MORE >

1 Introduction

1.1 Key Take-Aways

1.2 Report Description

1.3 Markets Covered

1.4 Stakeholders

1.5 Research Methodology

1.5.1 Market Size

1.5.2 Market Share

1.5.3 Key Data Points From Secondary Sources

1.5.4 Key Data Points From Primary Sources

2 Executive Summary

3 Market Overview

3.1 Introduction

3.2 Market Segmentation

3.3 Market Dynamics

3.3.1 Drivers

3.3.1.1 Increasing Demand For Diagnostic & Image Guided Procedures Influences Contrast Media Sales

3.3.1.2 Technological Advancements To Spur The Contrast Media Market

3.3.1.3 Increasing Incidence & Mortality Of Cancer & Cardiac Diseases To Boost Growth Of Contrast Media

3.3.1.4 Growth Of Medical Imaging Technology In Emerging Markets

3.3.2 Restraints

3.3.2.1 Major Economies Undergoing Healthcare Reforms To Affect The Sales On Contrast Media

3.3.2.2 Economic Slowdown To Inhibit Growth

3.3.3 Opportunities

3.3.3.1 Growing Investment Potential In Immature Emerging Markets

3.3.3.2 Advent Of Novel Contrast Agents Combining Properties Of Contrast Media & Radiopharmaceuticals

3.3.4 Burning Issue - Toxicity

3.3.4.1 Nephrogenic Systemic Fibrosis (Nsf)

3.3.4.2 Contrast-Induced Nephrotoxicity (Cin)

3.3.5 Technology Trends

3.3.5.1 N1177 – A Revolutionary Macrophage Labeling Agent

3.3.5.2 Spago Pix – Accurate Visualization Of Tumors With Mri

3.3.5.3 Cmc-001 – Focused On Liver Mri

3.4 Market Share Analysis

4 Global Contrast Media Market, By Product

4.1 Introduction

4.2 Barium-Based Contrast Media

4.2.1 Technical Overview

4.2.2 Market Dynamics

4.2.3 Market Analysis

4.3 Iodinated Contrast Media

4.3.1 Technical Overview

4.3.2 Market Dynamics

4.3.3 Market Analysis

4.3.4 Types – Low-Osmolar And High-Osmolar

4.3.4.1 Low-Osmolar Contrast Media (Locm)

4.3.4.1.1 Technical Overview

4.3.4.1.2 Market Analysis

4.3.4.2 High-Osmolar Contrast Media (Hocm)

4.3.4.2.1 Technical Overview

4.3.4.2.2 Market Analysis

4.4 Gadolinium-Based Contrast Media

4.4.1 Technical Overview

4.4.2 Market Dynamics

4.4.3 Market Analysis

5 Global Contrast Media Market, By Route Of Administration

5.1 Introduction

5.2 Oral Contrast Media

5.2.1 Technical Overview

5.2.2 Market Dynamics

5.2.3 Market Analysis

5.3 Injectable Contrast Media

5.3.1 Technical Overview

5.3.2 Market Dynamics

5.3.3 Market Analysis

5.3.4 Injectable Contrast Media – Types

5.3.4.1 Intravenous (Iv)

5.3.4.2 Intra-Arterial (Ia)

5.4 Rectal Contrast Media

5.4.1 Technical Overview

5.4.2 Market Dynamics

5.4.3 Market Analysis

5.5 Urethral Contrast Media

5.5.1 Technical Overview

5.5.2 Market Dynamics

5.5.3 Market Analysis

6 Global Contrast Media Market, By Medical Procedure

6.1 Introduction

6.2 X-Ray

6.2.1 Technical Overview

6.2.2 Market Dynamics

6.2.3 Market Analysis

6.3 Computed Tomography (Ct)

6.3.1 Technical Overview

6.3.2 Market Dynamics

6.3.3 Market Analysis

6.4 Magnetic Resonance Imaging (Mri)

6.4.1 Technical Overview

6.4.2 Market Dynamics

6.4.3 Market Analysis

6.5 Ultrasound

6.5.1 Technical Overview

6.5.2 Market Dynamics

6.5.3 Market Analysis

6.6 Catheterization Laboratory (Cath Lab)

6.6.1 Technical Overview

6.6.2 Market Dynamics

6.6.3 Market Analysis

7 Global Contrast Media Market, By Indication

7.1 Introduction

7.2 Cardiovascular Disorders

7.2.1 Market Dynamics

7.2.2 Market Analysis

7.3 Neurological Disorders

7.3.1 Market Dynamics

7.3.2 Market Analysis

7.4 Respiratory Diseases

7.4.1 Market Dynamics

7.4.2 Market Analysis

7.5 Gastrointestinal Disorders

7.5.1 Market Dynamics

7.5.2 Market Analysis

7.6 Oncology

7.6.1 Market Dynamics

7.6.2 Market Analysis

7.7 Musculoskeletal Anomalies

7.7.1 Market Dynamics

7.7.2 Market Analysis

7.8 Nephrological Disorders

7.8.1 Market Dynamics

7.8.2 Market Analysis

8 Global Contrast Media Market, By Application

8.1 Introduction

8.2 Radiology

8.2.1 Technical Overview

8.2.2 Market Dynamics

8.2.3 Market Analysis

8.3 Interventional Radiology

8.3.1 Technical Overview

8.3.2 Market Dynamics

8.3.3 Market Analysis

8.4 Interventional Cardiology

8.4.1 Technical Overview

8.4.2 Market Dynamics

8.4.3 Market Analysis

9 Geographic Analysis

9.1 Introduction

9.2 North America

9.3 Europe

9.4 Asia-Pacific

9.5 Rest Of The World (Row)

10 Competitive Landscape

10.1 Introduction

10.2 Mergers & Acquisitions

10.3 Agreements, Partnerships, Collaborations & Joint Ventures

10.4 New Product Launch

10.5 Expansion

10.6 Approvals

10.7 Other Developments

11 Company Profiles (Overview, Financials, Products & Services, Strategy, And Developments)*? Snapshot

11.1 Amag Pharmaceuticals, Inc.

11.2 Bayer Healthcare Pharmaceuticals

11.3 Bracco Imaging Spa (A Subsidiary Of Bracco S.P.A)

11.4 Covidien

11.5 Cmc Contrast Ab

11.6 Daiichi Sankyo Co., Ltd.

11.7 Ge Healthcare

11.8 Genovis Ab

11.9 Guerbet Group

11.10 Lantheus Medical Imaging, Inc.

11.11 Nanopet Pharma Gmbh

11.12 Nanoscan Imaging, Llc

11.13 Sanochemia Pharmazeutika Ag

11.14 Spago Imaging Ab (A Subsidiary Of Accelerator Nordic Ab)

11.15 Subhra Pharma Private, Ltd

11.16 Taejoon Pharm Co., Ltd.

11.17 Targeson, Inc.

11.18 Unijules Life Sciences, Ltd.

*Details On Financials, Product & Services, Strategy, And Developments Might Not Be Captured In Case Of Unlisted Companies.

List Of Tables

Table 1 Global Contrast Media Market, By Product, 2010 – 2017 ($Million)

Table 2 Contrast Media Market, By Geography, 2010 – 2017 ($Million)

Table 3 Classification Of Gbcas By U.S. Fda Based On Number Of Nsf Cases

Table 4 Global Contrast Media Market Revenue, By Product, 2010 - 2017 ($Million)

Table 5 Global Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 6 Barium-Based Contrast Media Market Revenue, By Geography, 2010-2017 ($Million)

Table 7 Iodinated Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 8 Iodinated Contrast Media Market Revenue, By Type, 2010 - 2017 ($Million)

Table 9 Iodinated-Locm Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 10 Iodinated-Hocm Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 11 Gadolinium-Based Contrast Media Market Revenue, By Geography, 2010 - 2017 ($Million)

Table 12 Global Contrast Media Market Revenue, By Route Of Administration, 2010 – 2017 ($Million)

Table 13 Oral Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 14 Injectable Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 15 Injectable Contrast Media Market Revenue, By Type, 2010 – 2017 ($Million)

Table 16 Intravenous Injectable Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 17 Intra-Arterial Injectable Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 18 Rectal Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 19 Urethral Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million) 85
Table 20 Global Contrast Media Market Revenue, By Medical Procedure, 2010 – 2017 ($Million)

Table 21 X-Ray Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 22 Ct Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 23 Mri Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 24 Ultrasound Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 25 Cath Lab Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 26 Global Contrast Media Market, By Indication, 2010 – 2017 ($Million)

Table 27 Cardiovascular Diseases - Contrast Media Market, By Geography, 2010 – 2017 ($Million)

Table 28 Neurological Disorders - Contrast Media Market, By Geography, 2010 – 2017 ($Million)

Table 29 Respiratory Diseases - Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 30 Gastrointestinal Disorders - Contrast Media Market, By Geography, 2010 – 2017 ($Million)

Table 31 Oncology - Contrast Media Market, By Geography, 2010 – 2017 ($Million)

Table 32 Musculoskeletal Anomalies – Contrast Media Market, By Geography, 2010 – 2017 ($Million)

Table 33 Nephrological Disorders - Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 34 Global Contrast Media Market Revenue, By Application, 2010 – 2017 ($Million)

Table 35 Radiology Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 36 Interventional Radiology Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 37 Interventional Cardiology Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 38 Contrast Media Market Revenue, By Geography, 2010 – 2017 ($Million)

Table 39 North America: Contrast Media Market, By Country, 2010 – 2017 ($Million)

Table 40 North America: Contrast Media Market, By Product, 2010 – 2017 ($Million)

Table 41 North America: Iodinated Contrast Media Market, By Type, 2010 – 2017 ($Million)

Table 42 North America: Contrast Media Market, By Application, 2010 – 2017 ($Million)

Table 43 North America: Contrast Media Market, By Indication, 2010 – 2017 ($Million)

Table 44 North America: Contrast Media Market, By Route Of Administration, 2010 – 2017 ($Million)

Table 45 North America: Injectable Contrast Media Market, By Type, 2010 – 2017 ($Million)

Table 46 North America: Contrast Media Market, By Medical Procedure, 2010 – 2017 ($Million)

Table 47 Europe: Contrast Media Market, By Country, 2010 – 2017 ($Million)

Table 48 Europe: Contrast Media Market, By Product, 2010 – 2017 ($Million)

Table 49 Europe: Iodinated Contrast Media Market, By Type, 2010 – 2017 ($Million)

Table 50 Europe: Contrast Media Market, By Application, 2010 – 2017 ($Million)

Table 51 Europe: Contrast Media Market, By Indication, 2010 – 2017 ($Million)

Table 52 Europe: Contrast Media Market, By Route Of Administration, 2010 – 2017 ($Million)

Table 53 Europe: Injectable Contrast Media Market, By Type, 2010 – 2017 ($Million)

Table 54 Europe: Contrast Media Market, By Medical Procedure, 2010 – 2017 ($Million)

Table 55 Apac: Contrast Media Market, By Country, 2010 – 2017 ($Million)

Table 56 Apac: Contrast Media Market, By Product, 2010 – 2017 ($Million)

Table 57 Apac: Iodinated Contrast Media Market, By Type, 2010 – 2017 ($Million)

Table 58 Apac: Contrast Media Market, By Application, 2010 – 2017 ($Million)

Table 59 Apac: Contrast Media Market, By Indication, 2010 – 2017 ($Million)

Table 60 Apac: Contrast Media Market, By Route Of Administration, 2010 – 2017 ($Million)

Table 61 Apac: Injectable Contrast Media Market, By Type, 2010 – 2017 ($Million)

Table 62 Apac: Contrast Media Market, By Medical Procedure, 2010 – 2017 ($Million)

Table 63 Row: Contrast Media Market Revenue, By Region, 2010 – 2017 ($Million)

Table 64 Row: Contrast Media Market Revenue, By Product, 2010 – 2017 ($Million)

Table 65 Row: Iodinated Contrast Media Market, By Type, 2010 – 2017 ($Million)

Table 66 Row: Contrast Media Market Revenue, By Application, 2010 – 2017 ($Million)

Table 67 Row: Contrast Media Market Revenue, By Indication, 2010 – 2017 ($Million)

Table 68 Row: Contrast Media Market Revenue, By Route Of Administration, 2010 – 2017 ($Million)

Table 69 Row: Injectable Contrast Media Market Revenue, By Type, 2010 – 2017 ($Million)

Table 70 Row: Contrast Media Market Revenue, By Medical Procedure, 2010 – 2017 ($Million)

Table 71 Mergers & Acquisitions, 2010 – 2012

Table 72 Agreements, Partnerships, Collaborations & Joint Ventures, 2010 – 2012

Table 73 New Product Launch, 2010 – 2012

Table 74 Expansion, 2010 – 2012

Table 75 Approvals, 2010 – 2012

Table 76 Other Developments, 2010 – 2012

Table 77 Amag Pharmaceuticals: Total Revenue And R&D Expenses, 2009 – 2011 ($Million)

Table 78 Amag Pharmaceuticals: Total Revenue, By Segment, 2009 – 2011 ($Million)

Table 79 Amag Pharmaceuticals: Total Product Sales, By Product, 2009 – 2011 ($Million)

Table 80 Bayer Healthcare Pharmaceuticals: Total Revenue And R&D Expenses, 2009 – 2011 ($Million)

Table 81 Bayer Healthcare Pharmaceuticals: Total Revenue, By Segment, 2009 – 2011 ($Million)

Table 82 Bayer Healthcare Pharmaceuticals: Total Revenue, By Geography, 2009 – 2011 ($Million)

Table 83 Bayer Healthcare Pharmaceuticals: Total Revenue Of Healthcare Segment, By Division, 2009 – 2011 ($Million)

Table 84 Bayer Healthcare Pharmaceuticals: Total Revenue Of Healthcare Segment, By Geography, 2009 – 2011 ($Million)

Table 85 Bayer Healthcare Pharmaceuticals: Total Revenue Of Consumer Health Division, By Segment, 2009 - 2011 ($Million)

Table 86 Bayer Healthcare Pharmaceuticals: Total Revenue Of Consumer Health Division, By Geography, 2009 – 2011 ($Million)

Table 87 Covidien: Net Sales And R&D Expenses, 2009 – 2011 ($Million)

Table 88 Covidien: Net Sales, By Segments, 2009 – 2011 ($Million)

Table 89 Covidien: Net Sales, By Pharmaceutical Products, 2009 – 2011 ($Million)

Table 90 Covidien: Net Sales, By Geography, 2009 – 2011 ($Million)

Table 91 Daiichi Sankyo Co., Ltd.: Net Sales And R&D Expenses, 2009 – 2011 ($Billion)

Table 92 Daiichi Sankyo Co., Ltd.: Net Sales, By Geography, 2009 – 2011 ($Million)

Table 93 General Electric: Total Revenue And R&D Expenses, 2009 – 2011 ($Billion)

Table 94 General Electric: Total Revenue, By Segments, 2009 – 2011 ($Billion)

Table 95 General Electric: Total Revenue, By Geography, 2009 – 2011 ($Billion)

Table 96 Genovis Ab: Total Revenue And R&D Expenses, 2010 – 2012 ($Thou.S.Nd)

Table 97 Genovis Ab: Total Revenue, By Geography, 2010 – 2012 ($Thou.S.Nd)

Table 98 Guerbet: Total Revenue And R&D Expenses, 2010 – 2012 ($Million)

Table 99 Guerbet: Total Revenue, By Products, 2010 – 2012 ($Million)

Table 100 Guerbet: Total Revenue, By Geography 2010 – 2012 ($Million)

Table 101 Lantheus: Total Revenue And R&D Expenses, 2009 – 2011 ($Million)

Table 102 Lantheus: Total Revenue, By Segment, 2009 – 2011 ($Million)

Table 103 Lantheus : Total Revenue, By Geography, 2009 – 2011 ($Million)

Table 104 Sanochemia Pharmazeutika Ag: Total Revenue And R&D Expenses, 2010 – 2012 ($Million)

Table 105 Sanochemia Pharmazeutika Ag: Total Revenue, By Segment, 2010 – 2011 ($Million)

Table 106 Sanochemia Pharmazeutika Ag: Total Revenue, By Geography, 2010 – 2012 ($Million)

Table 107 Accelerator Nordic Ab: Total Revenue And R&D Expenses, 2010 – 2012 ($Thou.S.Nd)

List Of Figures

Figure 1 Contrast Media Market, By Geography, 2010 – 2017 ($Million)

Figure 2 Contrast Media Market Segmentation

Figure 3 Market Dynamics

Figure 4 Global Contrast Media Market Share Analysis, By Key Players, 2011

Figure 5 Contrast Media Market Segmentation, By Product

Figure 6 Chemistry Of Low Osmolar Contrast Media (Locm)

Figure 7 Chemistry Of High-Osmolar Contrast Media (Hocm)

Figure 8 Contrast Media Market Segmentation, By Route Of Administration

Figure 9 Contrast Media Market Segmentation, By Medical Procedure

Figure 10 Contrast Media Market Segmentation, By Indication

Figure 11 Contrast Media Market Segmentation, By Application

Figure 12 Key Growth Strategies, 2010 – 2012

Figure 13 Key Players Focusing On Agreements, Partnerships, Collaborations & Joint Ventures Strategy, 2010 – 2012

Figure 14 Key Players Focusing On New Product Launch Strategy, 2010 – 2012

- Amag Pharmaceuticals, Inc.

- Bayer Healthcare Pharmaceuticals

- Bracco Imaging Spa (A Subsidiary Of Bracco S.P.A)

- Covidien

- Cmc Contrast Ab

- Daiichi Sankyo Co., Ltd.

- Ge Healthcare

- Genovis Ab

- Guerbet Group

- Lantheus Medical Imaging, Inc.

- Nanopet Pharma Gmbh

- Nanoscan Imaging, Llc

- Sanochemia Pharmazeutika Ag

- Spago Imaging Ab (A Subsidiary Of Accelerator Nordic Ab)

- Subhra Pharma Private, Ltd

- Taejoon Pharm Co., Ltd.

- Targeson, Inc.

- Unijules Life Sciences, Ltd.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos